Register Today!
June 11-13, 2017

Joseph B Martin Conference Center
at Harvard Medical School
Your Subtitle text

Jointly Provided by Boston University School of Medicine and Weston Medical Publishing, LLC.





Course Directors: Paul A. Sloan, MD, Michael J. Brennan, MD

CME Course Advisor: Daniel Alford, MD, MPH, FACP

Objectives: After attending this meeting participants should be able to:
•Describe the enhanced therapeutic benefits of various opioids and highlight indications for use in chronic and cancer pain.
•Explain various prescribing guidelines for treatment of pain, limiting the abuse of prescription opioid analgesics by carrying out the current prescription guidelines.
•Identify, diagnose, treat, or refer a patient with drug addiction.
•Recognize the legal and regulatory implications of prescribing opioids that arise when treating individuals in pain.
•Identify the basic pharmacology of new and existing opioids, and utilize and promote evidence-based approaches for clinical treatment.
•Describe the development of new sciences and explain the differences among formulations, including specific short-acting versus long-acting opioid analgesics.

Evaluations: Attendees will be directed to submit evaluations online for ICOO 2017. Space has been provided in the program guide  pages to make notes about the sessions you attend to help you fill out the online evaluation form. Please visit http://www.bucme.org/getcredit and enter the activity course code - XLN17126, Questions? Please call 800-688-2475.

How to Obtain CME/CEU Credit: Please visit http://www.bucme.org/getcredit and enter the activity course code - XLN17126 and follow the directions. Create a new account if you are a new user and complete the post conference evaluation. We request that you complete the conference evaluation and claim your credit before July 31, 2017.

Faculty Disclosure: Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices are being discussed.

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Weston Medical Publishing, LLC. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 18.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 18.25 hours of risk management study.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 18.25 hours of opioid education.

RN Credit: Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by Weston Medical Publishing, LLC.

Contact Hours: 18.25, of which up to 18.25 are eligible for pharmacology credit.

CPE Credit: The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 7.50 contact hours (0.75 ceus) on day one, 7.50 contact hours (0.75 ceus) on day two, and 3.5 (0.35 ceus) on day three of the “International Conference on Opioids” June 11-13, 2017.

Pharmacists must attend the full day of educational activities to earn ce credit for the day.

Universal Activity Numbers: International Conference on Opioids, Day One (Sunday June 11, 2017) UAN 0060-9999-17-036-L01-P
International Conference on Opioids, Day Two (Monday June 12, 2017) UAN 0060-9999-17-037-L01-P
International Conference on Opioids, Day Three (Tuesday June 13, 2017) UAN 0060-9999-17-038-L01-P



Disclaimer: THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY AND WESTON MEDICAL PUBLISHING, LLC MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY OR WESTON MEDICAL PUBLISHING, LLC BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

Off Label Statement: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The faculty have been asked to disclose this information when presented. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Cancellations: Should you be unable to attend, please inform us in writing prior to May 1, 2017 and a full refund less a 25% non-refundable deposit will be issued. No refunds or credits will be given for cancellations received on or after May 2, 2017. Substitutions of enrolled registrants must be made in writing. If for any reason this conference is cancelled, the conference organizers and sponsors do not accept responsibility for covering airfare, hotel or other costs incurred by conference registrants. The speakers and agenda of this program are subject to change without notice due to unforeseen circumstances beyond the control of conference presenters.

ADA Support: Boston University School of Medicine and Weston Medical Publishing, LLC fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Michael Glynn at 781-899-2702 Ext. 103 by May 1, 2017 in order to receive services.

The Journal of Opioid Management presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.         

The speakers and agenda of this program are subject to change without notice due to unforeseen circumstances beyond the control of conference presenters. © 2017 Weston Medical Pub., LLC  All Rights Reserved